The role of glucocorticoid in SIRP alpha and SHP-1 gene expression in AIHA patients.

Autor: de Almeida AC; Center for Investigation in Pediatrics and Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil., Barbosa SM, Barjas-Castro Mde L, Olalla-Saad ST, Condino-Neto A
Jazyk: angličtina
Zdroj: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2009; Vol. 31 (4), pp. 636-40.
DOI: 10.3109/08923970902939256
Abstrakt: The aim of this work was to evaluate the regulation of SIRP alpha, an inhibitory phagocyte receptor, and the phosphatase SHP-1 in monocytes of patients with autoimmune hemolytic anemia, and the role of dexamethasone on SIRP alpha and SHP-1 gene expression and erythrophagocytosis in vitro. SIRP alpha and SHP-1 expression was higher in monocytes from AIHA patients compared with normal, returning to normal after glucocorticoid therapy. SIRP alpha and SHP-1 mRNA expression was upregulated in healthy monocytes treated with dexamethasone compared with basal; however, the erythrophagocytic ability was not altered. Our results point to a minor role of SIRP alpha and SHP-1 in determining AIHA.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje